Citi Remains a Buy on CSPC Pharmaceutical Group (CHJTF)

Business Insider

6 days ago

In a report released yesterday, from Citi maintained a Buy rating on CSPC Pharmaceutical Group (CHJTF – Research Report), with a price target of HK$9.20.
Confident Investing Starts Here:
Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
In addition to Citi, CSPC Pharmaceutical Group also received a Buy from Morgan Stanley's Yolanda Hu in a report issued yesterday. However, on the same day, Macquarie maintained a Hold rating on CSPC Pharmaceutical Group (Other OTC: CHJTF).
The company has a one-year high of $0.96 and a one-year low of $0.44. Currently, CSPC Pharmaceutical Group has an average volume of 35.52K.